Skip to main content
. 2015 Apr 27;10(4):e0124839. doi: 10.1371/journal.pone.0124839

Fig 11. Anti-HIV activity of HbAHP-25 in the presence of seminal plasma and vaginal lavage.

Fig 11

Luciferase activity in TZM-bl cells infected with HIV-1 IIIB (a) or HIV-1 Ada (b) in the presence of seminal plasma/vaginal lavage mixed with various concentrations of HbAHP-25. Anti-HIV activity imparted by vaginal fluid and seminal plasma was subtracted from the HbAHP-25 treated wells. (Control: Inhibition of HIV-1 by HbAHP-25 in absence of seminal plasma and vaginal fluid; +Seminal Plasma: Anti-HIV activity of HbAHP-25 in presence of seminal fluid; and +Vaginal Lavage: Anti-HIV activity of HbAHP-25 in presence of vaginal lavage) (*p<0.05; **p<0.01; ***p<0.001).